These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21503185)

  • 21. The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?
    Martin F; Taylor GP
    J Antimicrob Chemother; 2009 Nov; 64(5):895-900. PubMed ID: 19706669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy.
    Mnyani CN; McIntyre JA; Myer L
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):260-4. PubMed ID: 22487589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil.
    Pilotto JH; Velasque LS; Friedman RK; Moreira RI; Veloso VG; Grinsztejn B; Morgado MG; Watts DH; Currier JS; Hoffman RM
    Antivir Ther; 2011; 16(3):349-56. PubMed ID: 21555817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysregulation of CD4+CD25+CD127lowFOXP3+ regulatory T cells in HIV-infected pregnant women.
    Kolte L; Gaardbo JC; Karlsson I; Sørensen AL; Ryder LP; Skogstrand K; Ladelund S; Nielsen SD
    Blood; 2011 Feb; 117(6):1861-8. PubMed ID: 21163930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception.
    Machado ES; Hofer CB; Costa TT; Nogueira SA; Oliveira RH; Abreu TF; Evangelista LA; Farias IF; Mercadante RT; Garcia MF; Neves RC; Costa VM; Lambert JS
    Sex Transm Infect; 2009 Apr; 85(2):82-7. PubMed ID: 18987014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022.
    Hitti J; Frenkel LM; Stek AM; Nachman SA; Baker D; Gonzalez-Garcia A; Provisor A; Thorpe EM; Paul ME; Foca M; Gandia J; Huang S; Wei LJ; Stevens LM; Watts DH; McNamara J;
    J Acquir Immune Defic Syndr; 2004 Jul; 36(3):772-6. PubMed ID: 15213559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to Kourtis et al. 'Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis'.
    Townsend CL; Cortina-Borja M; Peckham CS; Tookey PA
    AIDS; 2007 Aug; 21(13):1831-2. PubMed ID: 17690590
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?
    Thorne C; Newell ML
    Drug Saf; 2007; 30(3):203-13. PubMed ID: 17343429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maxillary herpes zoster with corneal involvement in a HIV positive pregnant woman.
    Omoti AE; Omoti CE
    Afr J Reprod Health; 2007 Apr; 11(1):133-6. PubMed ID: 17982956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased rates of preterm delivery are associated with the initiation of highly active antiretrovial therapy during pregnancy: a single-center cohort study.
    Martin F; Taylor GP
    J Infect Dis; 2007 Aug; 196(4):558-61. PubMed ID: 17624841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety issues about nevirapine administration in HIV-infected pregnant women.
    Manfredi R; Calza L
    J Acquir Immune Defic Syndr; 2007 Jul; 45(3):365-8. PubMed ID: 17592340
    [No Abstract]   [Full Text] [Related]  

  • 34. Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study.
    van der Merwe K; Hoffman R; Black V; Chersich M; Coovadia A; Rees H
    J Int AIDS Soc; 2011 Aug; 14():42. PubMed ID: 21843356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to Kourtis et al. 'Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis'.
    Patel D; Thorne C; Newell ML
    AIDS; 2007 Jul; 21(12):1656-7; author reply1657-8. PubMed ID: 17630567
    [No Abstract]   [Full Text] [Related]  

  • 36. Anaemia in HIV-infected pregnant women receiving triple antiretroviral combination therapy for prevention of mother-to-child transmission: a secondary analysis of the Kisumu breastfeeding study (KiBS).
    Odhiambo C; Zeh C; Angira F; Opollo V; Akinyi B; Masaba R; Williamson JM; Otieno J; Mills LA; Lecher SL; Thomas TK
    Trop Med Int Health; 2016 Mar; 21(3):373-84. PubMed ID: 26799167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening HIV-positive pregnant women for antiretroviral therapy: utility of self-reported symptoms.
    Nguyen RH; Gange SJ; Serwadda D; Kigozi G; Kiwanuka N; Sewankambo NK; Wabwire-Mangen F; Quinn TC; Wawer M; Gray RH
    Int J STD AIDS; 2006 Feb; 17(2):112-5. PubMed ID: 16464273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi.
    Weigel R; Hosseinipour MC; Feldacker C; Gareta D; Tweya H; Chiwoko J; Gumulira J; Kalulu M; Mofolo I; Kamanga E; Mwale G; Kadzakumanja A; Jere E; Phiri S
    Trop Med Int Health; 2012 Jun; 17(6):751-9. PubMed ID: 22487553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HIV and pregnancy].
    Petry KU
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():63-5. PubMed ID: 16385880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.